With AVAH Up 94% in a Month, Is It Time to Compare It Against SGRY?
Surgery Partners (SGRY) offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Aveanna Healthcare (AVAH), suggesting you may be better off investing in SGRY
- SGRY’s quarterly revenue growth was 12.0%, vs. AVAH’s 11.5%.
- In addition, its Last 12 Months revenue growth came in at 12.0%, ahead of AVAH’s 11.5%.
- SGRY leads on profitability over both periods – LTM margin of 14.3% and 3-year average of 14.5%.
AVAH provides private duty nursing, adult home health, hospice, pediatric therapy, and enteral nutrition services through three segments: Private Duty, Home Health & Hospice, and Medical Solutions. SGRY operates a network of 126 surgical facilities, including 108 ambulatory centers, providing surgical and ancillary services across the United States.
Valuation & Performance Overview
| AVAH | SGRY | Preferred | |
|---|---|---|---|
| Valuation | |||
| P/EBIT Ratio | 6.9 | 6.3 | SGRY |
| Revenue Growth | |||
| Last Quarter | 11.5% | 12.0% | SGRY |
| Last 12 Months | 11.5% | 12.0% | SGRY |
| Last 3 Year Average | 8.2% | 10.8% | SGRY |
| Operating Margins | |||
| Last 12 Months | 9.9% | 14.3% | SGRY |
| Last 3 Year Average | 6.4% | 14.5% | SGRY |
| Momentum | |||
| Last 3 Year Return | 285.4% | -23.1% | AVAH |
Note: For “Last 3 Year Return” metric, preferred stock is one with higher returns unless the returns are too high (>300%) which creates risk of sell off.
See more revenue details: AVAH Revenue Comparison | SGRY Revenue Comparison
See more margin details: AVAH Operating Income Comparison | SGRY Operating Income Comparison
But do these numbers tell the full story? Read Buy or Sell SGRY Stock to see if Surgery Partners’s edge holds up under the hood or if Aveanna Healthcare still has cards to play (see Buy or Sell AVAH Stock).
That is one way to look at stocks. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure
Historical Market Performance
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | Avg | Best | |
|---|---|---|---|---|---|---|---|---|---|
| Returns | |||||||||
| AVAH Return | – | – | -89% | 244% | 71% | 68% | 1% | ||
| SGRY Return | 85% | 84% | -48% | 15% | -34% | 9% | 51% | ||
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 10% | 100% | <=== | |
| Monthly Win Rates [3] | |||||||||
| AVAH Win Rate | – | 25% | 17% | 50% | 58% | 43% | 32% | ||
| SGRY Win Rate | 67% | 67% | 42% | 50% | 42% | 29% | 49% | ||
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 57% | 62% | <=== | |
| Max Drawdowns [4] | |||||||||
| AVAH Max Drawdown | – | – | -91% | -9% | -19% | -19% | -23% | ||
| SGRY Max Drawdown | -70% | -5% | -58% | -20% | -39% | -9% | -33% | ||
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | -12% | <=== | |
[1] Cumulative total returns since the beginning of 2020
[2] 2025 data is for the year up to 8/26/2025 (YTD)
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
No matter how good the numbers, stock investment is never a smooth ride. There is a risk you must factor in. Read SGRY Dip Buyer Analyses and AVAH Dip Buyer Analyses to see how these stocks have fallen and recovered in the past.